Skip to main content

. 1968 Jun 1;2(5604):533–535. doi: 10.1136/bmj.2.5604.533

Antilymphocytic serum and tumour dissemination.

K Hellmann, R I Hawkins, S Whitecross

PMCID: PMC1991827 PMID: 5724453

533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burnet F. M. Immunological aspects of malignant disease. Lancet. 1967 Jun 3;1(7501):1171–1174. doi: 10.1016/s0140-6736(67)92837-1. [DOI] [PubMed] [Google Scholar]
CHIRIGOS M. A., THOMAS L. B., HUMPHREYS S. R., GLYNN J. P., GOLDIN A. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT. Cancer Res. 1964 Apr;24:409–415. [PubMed] [Google Scholar]
KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
Karrer K., Humphreys S. R., Goldin A. An experimental model for studying factors which influence metastasis of malignant tumors. Int J Cancer. 1967 May 15;2(3):213–223. doi: 10.1002/ijc.2910020303. [DOI] [PubMed] [Google Scholar]
OLD L. J., BOYSE E. A. IMMUNOLOGY OF EXPERIMENTAL TUMORS. Annu Rev Med. 1964;15:167–186. doi: 10.1146/annurev.me.15.020164.001123. [DOI] [PubMed] [Google Scholar]
Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst. 1966 Apr;36(4):641–645. doi: 10.1093/jnci/36.4.641. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES